Total stockholders’ equity (deficiency) (2,958,866) as of 4/30/2020 7,672,599 as of 7/31/2019
So one of the key components of uplisting for GNBT is positive shareholder’s equity of $5M+. We are now at -$2,938,866
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.